Koichi Sugimoto

576 total citations
45 papers, 451 citations indexed

About

Koichi Sugimoto is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Urology. According to data from OpenAlex, Koichi Sugimoto has authored 45 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Urology. Recurrent topics in Koichi Sugimoto's work include Urinary Bladder and Prostate Research (9 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (5 papers). Koichi Sugimoto is often cited by papers focused on Urinary Bladder and Prostate Research (9 papers), Prostate Cancer Treatment and Research (6 papers) and Renal cell carcinoma treatment (5 papers). Koichi Sugimoto collaborates with scholars based in Japan, United States and United Kingdom. Koichi Sugimoto's co-authors include Kazuo Oshimi, Takashi Yokoyama, Masaaki Ishii, Nobuhito Hirawa, J. Iwai, Yasushi Isobe, Hirotsugu Uemura, Nobutaka Shimizu, Makoto Sasaki and Nanae Aritaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Koichi Sugimoto

43 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koichi Sugimoto Japan 11 93 89 83 63 61 45 451
Akif Çiftçioğlu Türkiye 14 36 0.4× 149 1.7× 16 0.2× 38 0.6× 72 1.2× 26 539
Hye Won Park South Korea 13 55 0.6× 210 2.4× 48 0.6× 46 0.7× 69 1.1× 37 550
Zhe Meng China 12 14 0.2× 216 2.4× 35 0.4× 49 0.8× 116 1.9× 24 635
Mona G. Amer Egypt 12 75 0.8× 126 1.4× 39 0.5× 37 0.6× 39 0.6× 34 518
Chi‐Feng Hung Taiwan 12 33 0.4× 145 1.6× 15 0.2× 36 0.6× 101 1.7× 25 476
Füsun Baba Türkiye 12 40 0.4× 123 1.4× 19 0.2× 39 0.6× 38 0.6× 27 489
Yulan Liu China 13 46 0.5× 121 1.4× 21 0.3× 113 1.8× 42 0.7× 39 544
Yuanjie Xie China 13 28 0.3× 282 3.2× 33 0.4× 42 0.7× 16 0.3× 20 839
Sibel Dinçer Türkiye 11 26 0.3× 66 0.7× 25 0.3× 40 0.6× 43 0.7× 29 446

Countries citing papers authored by Koichi Sugimoto

Since Specialization
Citations

This map shows the geographic impact of Koichi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Sugimoto more than expected).

Fields of papers citing papers by Koichi Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Sugimoto. The network helps show where Koichi Sugimoto may publish in the future.

Co-authorship network of co-authors of Koichi Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Sugimoto. A scholar is included among the top collaborators of Koichi Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Sugimoto. Koichi Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamada, Shohei, Koichi Sugimoto, Elghareeb E. Elboray, Takeo Kawabata, & Takumi Furuta. (2020). Chemoselective Oxidation ofp-Methoxybenzyl Ethers by an Electronically Tuned Nitroxyl Radical Catalyst. Organic Letters. 22(14). 5486–5490. 14 indexed citations
2.
Velasco, Marco A. De, Kazuko Sakai, Yuji Hatanaka, et al.. (2019). Targeting castration-resistant prostate cancer with androgen receptor antisense oligonucleotide therapy. JCI Insight. 4(17). 31 indexed citations
3.
Sugimoto, Koichi, Takenori Akiyama, Nobutaka Shimizu, et al.. (2017). Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case series. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Velasco, Marco A. De, Yuji Hatanaka, Takashi Oki, et al.. (2016). Abstract 4315: Effects of increased dietary fat consumption on prostate cancer progression in genetically engineered mice. Cancer Research. 76(14_Supplement). 4315–4315. 1 indexed citations
5.
Nozawa, Masahiro, Takahide Sugiyama, Koichi Sugimoto, et al.. (2015). Phase II study of degarelix/bicalutamide combination for prostate cancer.. Journal of Clinical Oncology. 33(15_suppl). e16005–e16005. 1 indexed citations
6.
Nozawa, Masahiro, Koichi Sugimoto, Takafumi Minami, et al.. (2015). Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma. International Journal of Clinical Oncology. 21(4). 748–755. 6 indexed citations
7.
Shimizu, Nobutaka, Takafumi Minami, Koichi Sugimoto, et al.. (2014). Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study. World Journal of Urology. 32(6). 1423–1432. 12 indexed citations
8.
Shimizu, Nobutaka, et al.. (2013). Survey on lower urinary tract symptoms and sleep disorders in patients treated at urology departments. Nature and Science of Sleep. 5. 7–7. 10 indexed citations
9.
Sugimoto, Koichi, et al.. (2013). Clinical Outcome of Small Renal Cell Carcinoma after Delayed Surgery versus Immediate Surgery. Journal of Cancer. 4(6). 514–518. 5 indexed citations
10.
Hatanaka, Yuji, Kiyoshi Hashimoto, Koichi Sugimoto, et al.. (2012). [Analysis of prognostic factor in 52 castration-resistant prostate cancer treated with docetaxel].. PubMed. 58(1). 7–11.
11.
Yasuda, Hajime, Yasushi Isobe, Makoto Sasaki, et al.. (2010). Suppression of eIF4E Expression by <i>L</i>-Asparaginase. Acta Haematologica. 123(4). 215–219. 5 indexed citations
12.
Sasaki, M., et al.. (2009). Establishment of a Hairy Cell Leukemia Variant Cell Line, HCLv-07. Acta Haematologica. 121(1). 63–66. 2 indexed citations
13.
Sugimoto, Koichi, Seiji Matsumoto, Hirotsugu Uemura, & Ito H. (2008). [Distribution of elastic fiber on prostate].. PubMed. 54(5). 321–4. 6 indexed citations
14.
Sugimoto, Koichi, et al.. (2006). A malignant Leydig cell tumor of the testis. International Urology and Nephrology. 38(2). 291–292. 10 indexed citations
15.
Sugimoto, Koichi, Kenji Tamayose, Masatoshi Takagi, et al.. (2000). Activation of an ataxia telangiectasia mutation‐dependent intra‐S‐phase checkpoint by anti‐tumour drugs in HL‐60 and human lymphoblastoid cells. British Journal of Haematology. 110(4). 819–825. 11 indexed citations
16.
Watanabe, Masahiro, Takuya Nomoto, Koichi Sugimoto, et al.. (1997). [Mass screening for prostatic cancer].. PubMed. 43(6). 447–52. 4 indexed citations
17.
Sugimoto, Koichi, et al.. (1995). Effect of green tea rich in ?-aminobutyric acid on blood pressure of Dahl salt-sensitive rats. American Journal of Hypertension. 8(1). 74–79. 135 indexed citations
18.
Sugimoto, Koichi, et al.. (1990). Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of multiple oral administration.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 21(3). 513–520. 1 indexed citations
19.
Sugimoto, Koichi, et al.. (1990). Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of single oral administration.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 21(3). 507–512. 2 indexed citations
20.
Misawa, Miwa, et al.. (1988). Effects of flutropium bromide, a new antiasthma drug, on mediator release from mast cells and actions of mediators.. Folia Pharmacologica Japonica. 91(2). 97–103. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akif Çiftçioğlu Breakdown of academic impact, for papers by Hye Won Park Breakdown of academic impact, for papers by Zhe Meng Breakdown of academic impact, for papers by Mona G. Amer Breakdown of academic impact, for papers by Chi‐Feng Hung Breakdown of academic impact, for papers by Füsun Baba Breakdown of academic impact, for papers by Yulan Liu Breakdown of academic impact, for papers by Yuanjie Xie Breakdown of academic impact, for papers by Sibel Dinçer
Rankless by CCL
2026